• LAST PRICE
    3.6600
  • TODAY'S CHANGE (%)
    Trending Up0.1600 (4.5714%)
  • Bid / Lots
    3.5000/ 3
  • Ask / Lots
    3.6500/ 1
  • Open / Previous Close
    3.4800 / 3.5000
  • Day Range
    Low 3.2800
    High 3.7000
  • 52 Week Range
    Low 1.9000
    High 8.4800
  • Volume
    40,748
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.5
TimeVolumeCASI
09:32 ET2583.408
09:34 ET4003.42
09:36 ET1003.42
09:38 ET1003.42
09:52 ET1003.41
10:17 ET5043.35
10:26 ET1503.3265
10:37 ET8113.3
10:39 ET7003.35
10:53 ET2003.35
11:42 ET6003.36
11:44 ET14003.3
11:45 ET4003.3062
12:00 ET2003.38
12:07 ET2003.4
12:18 ET3003.4
12:25 ET6003.4
12:27 ET3003.45
12:30 ET1003.44
12:52 ET9673.301
01:30 ET56223.3001
01:32 ET21003.4
01:33 ET7983.4
01:37 ET1003.4
01:46 ET44673.42
01:48 ET3503.5
02:18 ET3763.501
02:20 ET20003.51
02:26 ET14303.5
02:36 ET1003.51
02:45 ET1003.5
03:02 ET1003.51
03:09 ET1003.51
03:12 ET3503.545
03:20 ET3003.54
03:43 ET1003.5352
03:45 ET1003.58
03:52 ET62003.62
03:54 ET29633.66
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCASI
CASI Pharmaceuticals Inc
49.0M
-1.6x
---
United StatesMALG
Microalliance Group Inc
36.6M
4.4x
---
United StatesEQ
Equillium Inc
23.4M
-1.9x
---
United StatesMRNS
Marinus Pharmaceuticals Inc
73.1M
-0.5x
---
United StatesBFRI
Biofrontera Inc
4.8M
-0.1x
---
United StatesBON
Bon Natural Life Ltd
8.7M
0.4x
+78.05%
As of 2024-06-23

Company Information

CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. Its commercial product, EVOMELA, is an intravenous formulation of melphalan commercialized by Acrotech in the multiple myeloma treatment setting in the United States. Its pipeline products include CNCT19 (CD19 CAR-T), BI-1206 (anti- FcYRIIB antibody), CB-5339 (VCP/p97 inhibitor), CID-103 (Anti-CD38 Mab), Thiotepa, and Octreotide LAI. The Company’s Food and Drug Administration (FDA)-approved generic products for the China market include Entecavir tablets, Tenofovir disoproxil fumarate (TDF) tablets, Cilostazol tablets-50mg, Cilostazol tablets-100mg, Ondansetron HCL tablets, and Tizanidine tablets.

Contact Information

Headquarters
9620 Medical Center Drive, Suite 300BEIJING, BEJ, China 100025
Phone
106-561-8789
Fax
301-315-2437

Executives

Chairman of the Board, Chief Executive Officer
Wei-Wu He
President, Principal Financial Officer
Wei Zhang
Chief Operating Officer
Chunhua Wang
Global Chief Commercial Officer, Executive Vice President, General Manager of Casi China
Huang Hai
Executive Vice President, Chief Medical Officer
Alexander Zukiwski

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$49.0M
Revenue (TTM)
$28.9M
Shares Outstanding
13.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.58
EPS
$-2.28
Book Value
$1.81
P/E Ratio
-1.6x
Price/Sales (TTM)
1.7
Price/Cash Flow (TTM)
---
Operating Margin
-101.35%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.